Morgan Stanley 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 12:44 pm Sale | 2026-03-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | MORGAN STANLEY MS | 1,333,420 4.800% | -636,365 (-32.31%) | Filing |
| 2026-02-11 1:38 pm Purchase | 2025-12-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | MORGAN STANLEY MS | 1,969,785 7.000% | 1,185,157 (+151.05%) | Filing |
| 2025-11-07 12:45 pm Purchase | 2025-09-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | MORGAN STANLEY MS | 784,628 2.800% | 26,175 (+3.45%) | Filing |
| 2025-08-06 4:46 pm Purchase | 2025-06-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | MORGAN STANLEY MS | 758,453 5.000% | 758,453 (New Position) | Filing |